150
Participants
Start Date
September 30, 2000
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
Pentostatin
"Given intravenously on days +8, +15, +22 and +30 post transplant:~Group 2 - Pentostatin 0.5 mg/m\^2~Group 3 - Pentostatin 1 mg/m\^2~Group 4 - Pentostatin 1.5 mg/m\^2~Group 5 - Pentostatin 2 mg/m\^2"
Tacrolimus
Given intravenously from day -2, and will be switched to oral dosing when tolerated.
Methotrexate
Given intravenously on days +1, +3, and +6 at the dose of 5 mg/m2.
U.T.M.D. Anderson Cancer Center, Houston
Collaborators (1)
Astex Pharmaceuticals, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER